Pricing Log in Create free account

Creative Medical Technology Holdings, Inc. (CELZ) vs Xenetic Biosciences, Inc. (XBIO)

Creative Medical Technology Holdings, Inc. and Xenetic Biosciences, Inc. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. is the larger, with a market value of $5.1M against $4.5M — 1.1× the size. Xenetic Biosciences, Inc. grew revenue faster over the last twelve months: 33.3% against −79.4%. Creative Medical Technology Holdings, Inc. has the higher net margin (0.00% vs −75.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Xenetic Biosciences, Inc. leads on 10 and Creative Medical Technology Holdings, Inc. on 7.

Valuation

Metric CELZ XBIO Biotechnology median
P/E n/m n/m 8.58
P/S 165.49 1.34 10.29
P/B 0.32 0.72 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA 0.96 0.37 0.67
EV/Sales (347.51) (0.30) 9.89
Earnings yield (272.37%) (61.05%) (31.56%)
Free cash flow yield (398.93%) (53.01%) (23.42%)

Profitability

Metric CELZ XBIO Biotechnology median
Gross margin 61.18% 100.00% 65.77%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity (77.91%) (47.05%) (54.09%)
Return on assets (73.30%) (40.17%) (47.78%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELZ XBIO Biotechnology median
Revenue growth (TTM) (79.42%) 33.30% 5.83%
EPS growth (last fiscal year) 32.08% 38.52% 29.36%
Revenue growth, 5-year CAGR (48.43%) 46.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.91 7.43 4.80
Net debt to EBITDA 1.20 2.78 0.97

Dividend

Metric CELZ XBIO Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric CELZ XBIO Biotechnology median
Market cap 5.10m 4.52m 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack